Navigation Links
AnaptysBio Develops Novel Antibody Scaffold With Extreme Thermostability
Date:12/4/2012

SAN DIEGO, Dec. 4, 2012 /PRNewswire/ -- AnaptysBio, Inc., a privately-held therapeutic antibody company, today announced the publication of a novel full-length antibody scaffold, applicable to the development of highly thermostable antibodies for therapeutic and diagnostic applications, in the journal of Protein Engineering, Design & Selection (PEDS).  

(Logo:  http://photos.prnewswire.com/prnh/20111205/SF16052LOGO)

Entitled "An integrated approach to extreme thermostabilization and affinity maturation of an antibody", Dr. David J. King, chief scientific officer of AnaptysBio, and his team describe a novel IgG scaffold that maintains high binding affinity to its target antigen despite exposure to high temperature conditions for extended periods.   Accelerated stability data indicates that antibodies generated using this technology would remain stable at room temperature for several years.

To date, this novel approach has been successfully utilized by AnaptysBio to generate highly stable antibodies against multiple antigens.  As demonstrated in the aforementioned publication, existing antibodies with poor stability parameters can be effectively transformed by AnaptysBio's SHM-XEL platform to confer high thermal stability, while simultaneously improving binding affinity.   In addition, AnaptysBio has designed diverse library repertoires that permit de novo discovery of high thermostability antibodies in the context of its proprietary SHM-XEL platform. 

"To our knowledge, this publication describes the most stable full-length antibody reported to date," said Hamza Suria, president & chief executive officer of AnaptysBio. "Our ability to generate antibodies with extended room temperature thermostability provides a significant commercial advantage to future antibody-based therapeutic and diagnostic products.  Enhanced thermostability would reduce, or even eliminate, cold chain dependency during production, shipping and storage of antibody products.  These advantages may be particularly useful in developing countries, where the availability of antibody products is often constrained by dependency on refrigeration systems."

About AnaptysBio

Founded in 2005, AnaptysBio, Inc. is a privately-held company focused on the generation of antibody therapeutics, and the leader in the use of somatic hypermutation (SHM) for antibody discovery and optimization. AnaptysBio's proprietary SHM-XEL platform, which couples fully human antibody libraries with in vitro somatic hypermutation (SHM) in mammalian cells to generate high affinity lead candidates, replicates key features of the human immune system and overcomes limitations of prior antibody technologies.  By harnessing the natural mechanism of antibody maturation under controlled conditions, SHM-XEL allows for the selection of optimal antibody properties such as high affinity, function, cross-reactivity, epitope diversity and manufacturability.   AnaptysBio has established broad intellectual property around the use of SHM and is currently building a pipeline of novel therapeutic antibody product candidates, including differentiated programs in cancer immunotherapy, inflammation, muscle wasting disorders and antibody-drug conjugate applications. The Company has previously announced pharma partnerships with Merck, Roche, Novartis, Celgene and Gilead.  Major investors in AnaptysBio include Alloy Ventures, Avalon Ventures, Frazier Healthcare Ventures and Novo A/S.  For more information, visit www.anaptysbio.com.

 


'/>"/>
SOURCE AnaptysBio, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Anaptysbio Expands Leadership Team With Addition Of Dr. Andrew J. Mcknight
2. Army Researcher Develops Potential Vaccine Carrier That May Give Stockpiling Efforts A Shot In The Arm
3. Millennium Surgical Corp. Develops Online Sterilization Resource Center
4. Softway Solutions Develops Award-Winning Health App for Texas Heart Institute
5. World Renowned Inventor, Donald Spector, Develops Patent For Wireless Electric Acupuncture Patches
6. China Health Resource Develops Revolutionary Migraine Medication
7. Synapse Develops Technology for Innovative Asthma Management Device
8. Life Technologies Develops Simplified SAME-DAY STEC Solution for Detecting Multiple Strains of E. coli in Ground Beef
9. Ventana Medical Systems, Inc. develops first-ever fully automated dual-stain technique for miRNA and protein detection in cancer
10. AVT Develops New Line of Automated Stores For the Healthcare Industry
11. Particle Sciences Develops Novel Ocular Formulation for Eyeon Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... York , February 5, 2016 ... Transparency Market Research report states that the global active ... 2014 and is predicted to reach US$185.9 bn by ... of 6.50% from 2014 to 2020. The title of ... Chemical/Biological, Captive/Contract Manufactured, by Geography, and by Therapeutic Area) ...
(Date:2/5/2016)... , Feb. 5, 2016  Henry Schein, Inc. (NASDAQ: ... products and services to office-based dental, animal health and ... an agreement to acquire a majority ownership interest in ... equipment in Brazil . ... Blumenau, Brazil, Dental Cremer is the dental distribution business of ...
(Date:2/4/2016)... DUBLIN, Ohio , Feb. 4, 2016 ... Pricing Program, or those already participating in the program, ... Guidance, often referred to as the , Mega-Guidance , ... the final guidance is published in September 2016. ... 340B Product and Service Marketing , summarizes the Mega-Guidance,s ...
Breaking Medicine Technology:
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Today, the ... , announced that the much-anticipated feature with author Jahnavi Foster, specialist in healthy vegetarian ... TV Network. , Each week, on his weekly Whole-Food Warrior TV show, Frank Davis ...
(Date:2/5/2016)... ... February 05, 2016 , ... Francisco Canales, MD and ... their Napa Valley office. The technique utilizes the body’s own healing abilities to ... Dr. Furnas, are part of only a select few cosmetic surgeons bringing this ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... exclusively to funding innovative lymphoma research and serving the lymphoma community through a ... to once again host, Swirl, A Wine Tasting Event at the La Gorce ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Regular gym ... find themselves having to wait longer to access the treadmills. It’s a predictable trend. ... resolutions to lose weight and get in shape by joining gyms, starting new walking ...
(Date:2/5/2016)... ... February 05, 2016 , ... At its annual meeting held ... as Chairman of the National Board of Directors. Mr. McDermott succeeds former APDA Chairman, ... stated Leslie A. Chambers , APDA President and CEO. “Pat has tirelessly served ...
Breaking Medicine News(10 mins):